Evidence map›Paper›PMID 27590321›Full record

ArticleAnalytical and bioanalytical chemistry2017

A novel toolbox for E. coli lysis monitoring.

Vignesh Rajamanickam, David Wurm, Christoph Slouka, Christoph Herwig, Oliver Spadiut

Open access · hybridAbstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Secretion of recombinant proteins fromEngineering in life sciences · 2018
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vignesh RajamanickamResearch Division Biochemical Engineering, Institute of Chemical Engineering, Vienna University of Technology, Getreidemarkt 9/166, 1060, Vienna, Austria.
David WurmResearch Division Biochemical Engineering, Institute of Chemical Engineering, Vienna University of Technology, Getreidemarkt 9/166, 1060, Vienna, Austria.
Christoph SloukaResearch Division Biochemical Engineering, Institute of Chemical Engineering, Vienna University of Technology, Getreidemarkt 9/166, 1060, Vienna, Austria.
Christoph HerwigResearch Division Biochemical Engineering, Institute of Chemical Engineering, Vienna University of Technology, Getreidemarkt 9/166, 1060, Vienna, Austria.
Oliver SpadiutResearch Division Biochemical Engineering, Institute of Chemical Engineering, Vienna University of Technology, Getreidemarkt 9/166, 1060, Vienna, Austria. oliver.spadiut@tuwien.ac.at.ORCID http://orcid.org/0000-0003-0916-0644
TU Wien · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The bacterium Escherichia coli is a well-studied recombinant host organism with a plethora of applications in biotechnology. Highly valuable biopharmaceuticals, such as antibody fragments and growth factors, are currently being produced in E. coli. However, the high metabolic burden during recombinant protein production can lead to cell death, consequent lysis, and undesired product loss. Thus, fast and precise analyzers to monitor E. coli bioprocesses and to retrieve key process information, such as the optimal time point of harvest, are needed. However, such reliable monitoring tools are still scarce to date. In this study, we cultivated an E. coli strain producing a recombinant single-chain antibody fragment in the cytoplasm. In bioreactor cultivations, we purposely triggered cell lysis by pH ramps. We developed a novel toolbox using UV chromatograms as fingerprints and chemometric techniques to monitor these lysis events and used flow cytometry (FCM) as reference method to quantify viability offline. Summarizing, we were able to show that a novel toolbox comprising HPLC chromatogram fingerprinting and data science tools allowed the identification of E. coli lysis in a fast and reliable manner. We are convinced that this toolbox will not only facilitate E. coli bioprocess monitoring but will also allow enhanced process control in the future.

Indexed as

AntibodiesBacteriological TechniquesBioreactorsBiotechnologyChromatographyEscherichia coliRecombinant ProteinsAntibodiesRecombinant ProteinsBioprocess monitoringChromatogram fingerprintingData science toolsEscherichia coliHPLCLysis

Identifiers

PMID27590321
PMCPMC5233743
OpenAlexW2507481811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.